Lifecore Biomedical, Inc.
LFCR · NASDAQ
5/25/2025 | 5/26/2024 | 5/28/2023 | 5/29/2022 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$38,717 | $12,013 | -$99,563 | -$116,715 |
| Dep. & Amort. | $8,027 | $7,954 | $13,177 | $18,061 |
| Deferred Tax | $0 | $163 | $357 | -$6,825 |
| Stock-Based Comp. | $10,158 | $6,201 | $3,612 | $2,608 |
| Change in WC | -$4,695 | -$3,699 | $19,791 | -$3,101 |
| Other Non-Cash | $25,021 | -$22,375 | $45,185 | $83,379 |
| Operating Cash Flow | -$206 | $257 | -$17,441 | -$22,593 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$13,415 | -$18,395 | -$21,482 | -$29,940 |
| Net Acquisitions | $7,000 | $0 | $16,671 | $73,500 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $45,100 |
| Other Inv. Act. | $0 | $0 | $0 | -$8,698 |
| Investing Cash Flow | -$6,415 | -$18,395 | -$4,811 | $79,962 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$18,556 | $2,168 | $3,120 | -$55,411 |
| Stock Issued | $23,850 | $0 | $4,822 | $0 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $1,130 | $5,341 | $31,758 | -$1,610 |
| Financing Cash Flow | $6,424 | $7,509 | $39,700 | -$57,021 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$197 | -$10,629 | $17,448 | $348 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $8,462 | $19,091 | $1,643 | $1,295 |
| End Cash | $8,265 | $8,462 | $19,091 | $1,643 |
| Free Cash Flow | -$13,621 | -$18,138 | -$38,923 | -$52,533 |